Norelgestromin And Ethinyl Estradiol Patch
Product Images NDC 70710-1190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Norelgestromin And Ethinyl Estradiol (NDC 70710-1190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2.3 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 01)

FDA Label Image

Figure2 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 02)

FDA Label Image

Figure-2 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 03)

Figure-2 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 03)
This text provides information about different studies conducted on women's contraceptive use. The studies include the NICHD Women's Contraceptive Study in 2002, the French E3N cohort Study in 2005, the Shanghai Women's Health Study in 2009, The Nurses' Health Study II in 2010, the Oxford Family Planning Association Study in 2013, and the Danish Sex Hormone Register Study in 2017. The data includes information on ever use and current use of contraceptives. The text also presents effect estimates in terms of odds ratios or relative risks for different outcomes or variables. However, the has not provided readable values for the effect estimates, so this specific information is not available.*
FDA Label Image

Structure (Bf1e449e 61d5 4038 B03c 8b9d576060c0 04)

Structure (Bf1e449e 61d5 4038 B03c 8b9d576060c0 04)
norelgestromin ethinyl estradiol is a combination of two hormones, norelgestromin and ethinyl estradiol. It is commonly used as a contraceptive method to prevent pregnancy. This medication is available in various forms, such as patches, and is applied to the skin. It works by preventing the release of an egg from the ovary and by making the cervical mucus thicker, which hinders the movement of sperm. It is important to note that this description is based on the provided text, which may not be complete.*
FDA Label Image

Figure3 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 05)

FDA Label Image

Figure4 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 06)

FDA Label Image

Figure5 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 07)

FDA Label Image

Figure6 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 08)

Figure6 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 08)
Not available.*
FDA Label Image

Ifu-1 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 09)

FDA Label Image

Ifu-2 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 10)

FDA Label Image

Ifu-3 (Bf1e449e 61d5 4038 B03c 8b9d576060c0 11)

FDA Label Image

Carton (Bf1e449e 61d5 4038 B03c 8b9d576060c0 12)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 232 2)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 232 3)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 232 4)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 232 5)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 244 2)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 244 3)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 244 4)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 52 2)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 52 3)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 52 4)

FDA Label Image

Image (Bf1e449e 61d5 4038 B03c 8b9d576060c0 52 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.